<i>TMEM106B</i> regulates progranulin levels and the penetrance of FTLD in <i>GRN</i> mutation carriers

In our study, TMEM106B SNPs significantly reduced the disease penetrance in patients with GRN mutations, potentially by modulating GRN levels. These findings hold promise for the development of future protective therapies for FTLD.